The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Manerix 150 mg Film-coated Tablets

Mylan IRE Healthcare LimitedPA2010/023/001

Main Information

Trade NameManerix 150 mg Film-coated Tablets
Active SubstancesMoclobemide
Dosage FormFilm-coated tablet
Licence HolderMylan IRE Healthcare Limited
Licence NumberPA2010/023/001

Group Information

ATC CodeN06AG Monoamine oxidase A inhibitors
N06AG02 moclobemide


License statusAuthorised
Licence Issued04/07/1991
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back